Cerebrovascular accidents in paediatric patients supported by the Berlin Heart EXCOR

Sofie Rohde1, Eugen Sandica2, Kevin Veen1

  • 1Department of Cardio-thoracic surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.

Insights

Cerebrovascular accidents occurred in 20% of pediatric patients on Berlin Heart EXCOR support, with pump thrombosis and need for a second device being key risk factors. Mortality rates decreased, and recovery rates were encouraging.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Neurology

Background:

  • Ventricular assist device (VAD) support is a critical therapy for children awaiting cardiac transplantation.
  • The Berlin Heart EXCOR is a widely used VAD in pediatric patients.
  • Cerebrovascular accidents (CVAs) are a significant concern in patients with VADs.

Purpose of the Study:

  • To investigate the incidence of cerebrovascular accidents (CVAs) in pediatric patients supported by the Berlin Heart EXCOR ventricular assist device.
  • To identify factors associated with CVAs in this patient population.

Main Methods:

  • Retrospective analysis of pediatric patients (<19 years) supported by Berlin Heart EXCOR from January 2011 to January 2021.
  • Data sourced from the European Registry for Patients with Mechanical Circulatory Support.
  • Statistical analysis to determine incidence and associated factors for CVAs.

Main Results:

  • Of 230 patients, 46 (20.0%) experienced 55 CVAs, with 70.9% occurring within 90 days of VAD implantation.
  • Pump thrombosis (HR 1.998, P=0.040) and the need for a secondary right ventricular assist device (HR 11.300, P=0.037) were significantly associated with CVAs.
  • One-year outcomes included 44.4% transplant, 13.1% weaned, and 24.5% mortality, with a decreasing trend in mortality rates.

Conclusions:

  • Pediatric VAD support, particularly early after implantation, is linked to adverse events like CVAs.
  • Pump thrombosis and the need for a secondary RVAD are identified as significant risk factors for CVAs.
  • Encouraging recovery rates and declining mortality highlight the benefits, though improved data registry completeness is needed.
Abstract